EGFR G724S
|
NSCLC
|
EGFR G724S
|
NSCLC
|
osimertinib Resistant: C3 – Early Trials
|
osimertinib Resistant: C3 – Early Trials
|
EGFR G724S
|
NSCLC
|
EGFR G724S
|
NSCLC
|
afatinib Sensitive: C3 – Early Trials
|
afatinib Sensitive: C3 – Early Trials
|
EGFR G724S
|
Colon Cancer
|
EGFR G724S
|
Colon Cancer
|
cetuximab Sensitive: D – Preclinical
|
cetuximab Sensitive: D – Preclinical
|